These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17117454)

  • 21. Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis.
    Ratner PH; Wingertzahn MA; van Bavel JH; Hampel F; Darken PF; Hellbardt S; Brookman S; Shah T
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):657-63. PubMed ID: 17165276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous Determination of Ciclesonide and Active Metabolite Desisobutyryl-Ciclesonide in Human Serum and Its Application to a Clinical Study.
    Chen YL; Wang W; Gatien Ngounou Wetie A; Shi L; Eddy J; John Lin ZP; Sunkaraneni S
    J Appl Lab Med; 2020 Jan; 5(1):41-53. PubMed ID: 31662413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model-based covariate pharmacokinetic analysis and lack of cortisol suppression by the new inhaled corticosteroid ciclesonide using a novel cortisol release model.
    Rohatagi S; Krishnaswami S; Pfister M; Sahasranaman S
    Am J Ther; 2005; 12(5):385-97. PubMed ID: 16148423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of ciclesonide and its active metabolite desisobutyryl-ciclesonide in human plasma by LC-APCI-MS/MS: application to pharmacokinetic study in healthy Chinese volunteers.
    Su MX; Song M; Zhuang Y; Wang YQ; Hang TJ
    J Pharm Biomed Anal; 2011 Apr; 55(1):230-5. PubMed ID: 21296519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide.
    Stoeck M; Riedel R; Hochhaus G; Häfner D; Masso JM; Schmidt B; Hatzelmann A; Marx D; Bundschuh DS
    J Pharmacol Exp Ther; 2004 Apr; 309(1):249-58. PubMed ID: 14718604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar.
    Nave R; Gunawardena KA; Zech K; Bethke TD
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):1-7. PubMed ID: 16425964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of enzymes involved in phase I metabolism of ciclesonide by human liver microsomes.
    Peet CF; Enos T; Nave R; Zech K; Hall M
    Eur J Drug Metab Pharmacokinet; 2005; 30(4):275-86. PubMed ID: 16435573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
    Xu J; Nave R; Lahu G; Derom E; Derendorf H
    J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciclesonide disposition and metabolism: pharmacokinetics, metabolism, and excretion in the mouse, rat, rabbit, and dog.
    Guo Z; Gu Z; Howell SR; Chen K; Rohatagi S; Cai L; Wu J; Stuhler J
    Am J Ther; 2006; 13(6):490-501. PubMed ID: 17122529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine-activated bronchial epithelial cell pro-inflammatory functions are effectively downregulated in vitro by ciclesonide.
    Silvestri M; Serpero L; Petecchia L; Sabatini F; Cerasoli F; Rossi GA
    Pulm Pharmacol Ther; 2006; 19(3):210-7. PubMed ID: 16084120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma.
    Newman S; Salmon A; Nave R; Drollmann A
    Respir Med; 2006 Mar; 100(3):375-84. PubMed ID: 16275052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar Results in Children with Asthma for Steady State Pharmacokinetic Parameters of Ciclesonide Inhaled with or without Spacer.
    Boss H; Minic P; Nave R
    Clin Med Insights Pediatr; 2010; 4():1-10. PubMed ID: 23761990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in endogenous esterification and retention in the rat trachea between budesonide and ciclesonide active metabolite.
    Lexmüller K; Gullstrand H; Axelsson BO; Sjölin P; Korn SH; Silberstein DS; Miller-Larsson A
    Drug Metab Dispos; 2007 Oct; 35(10):1788-96. PubMed ID: 17627977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate.
    Kaliner MA
    Clin Ther; 2006 Mar; 28(3):319-31. PubMed ID: 16750447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of human lung fibroblast functions by ciclesonide: evidence for its conversion into the active metabolite desisobutyryl-ciclesonide.
    Boero S; Sabatini F; Silvestri M; Petecchia L; Nachira A; Pezzolo A; Scarso L; Rossi GA
    Immunol Lett; 2007 Sep; 112(1):39-46. PubMed ID: 17707916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of pharmacokinetic drug-drug interaction between ciclesonide and erythromycin.
    Nave R; Drollmann A; Steinijans VW; Zech K; Bethke TD
    Int J Clin Pharmacol Ther; 2005 Jun; 43(6):264-70. PubMed ID: 15968883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of lung deposition following inhalation of ciclesonide using different bioanalytical procedures.
    Nave R
    Bioanalysis; 2010 Apr; 2(4):807-14. PubMed ID: 21083275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma.
    Belvisi MG; Bundschuh DS; Stoeck M; Wicks S; Underwood S; Battram CH; Haddad el-B; Webber SE; Foster ML
    J Pharmacol Exp Ther; 2005 Aug; 314(2):568-74. PubMed ID: 15878996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol, 80 or 160 μg once daily, for the treatment of seasonal allergic rhinitis.
    Ratner P; Jacobs R; Mohar D; Huang H; Desai SY; Hinkle J
    Ann Allergy Asthma Immunol; 2010 Dec; 105(6):471-9. PubMed ID: 21130386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.